Self-control of long-term oral anticoagulation using a point-of-care device.
Roudaut
Raymond
R
D000074:Acenocoumarol / Q000627:therapeutic use; D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D016903:Drug Monitoring / Q000295:instrumentation / Q000379:methods*; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D019934:International Normalized Ratio / Q000295:instrumentation; D010630:Phenindione / Q000031:analogs & derivatives / Q000627:therapeutic use; D019095:Point-of-Care Systems; D017410:Practice Guidelines as Topic; D012648:Self Care / Q000295:instrumentation; D013923:Thromboembolism / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D013997:Time Factors; D016896:Treatment Outcome
D000925:Anticoagulants; D010630:Phenindione; C017673:fluindione; D000074:Acenocoumarol